Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2018-07
-
Protein A/G Magnetic Beads for Antibody Purification and IP
2026-06-08
Protein A/G Magnetic Beads enable efficient, low-background antibody purification and robust immunoprecipitation from complex biological samples. These recombinant Protein A and Protein G beads facilitate protein-protein interaction analysis, with minimized non-specific binding. APExBIO's K1305 product is validated for key immunological workflows.
-
AZD0156: Advanced ATM Kinase Inhibitor for DNA Repair Studie
2026-06-08
AZD0156 enables precise interrogation of ATM-mediated DNA damage response and reveals unique metabolic vulnerabilities in cancer cells. This guide translates reference-backed findings into actionable workflows, troubleshooting tips, and comparative insights for maximizing experimental success with APExBIO's highly selective ATM kinase inhibitor.
-
Septin4 Accelerates HIF-1α Degradation and Cardiomyocyte Apo
2026-06-07
This study reveals that Septin4 promotes apoptosis in hypoxia-exposed cardiomyocytes by enhancing the VHL-mediated degradation of the cardio-protective factor HIF-1α. These findings provide mechanistic insight into myocardial injury under hypoxic conditions and suggest potential therapeutic avenues targeting the HIF pathway.
-
ATRX Loss Sensitizes Glioma to RTK/PDGFR Inhibitors: Insight
2026-06-06
Pladevall-Morera et al. identify that high-grade glioma cells lacking the chromatin remodeler ATRX are more vulnerable to receptor tyrosine kinase (RTK) and PDGFR inhibitors. Their systematic drug screening and mechanistic assays suggest ATRX status as a critical factor for interpreting targeted therapy responses and designing combinatorial treatment strategies.
-
Streptavidin-FITC (SKU K1081): Reliable Biotin Detection in
2026-06-05
This article addresses key challenges in cell-based assays and demonstrates how Streptavidin-FITC (SKU K1081) delivers reproducible, high-sensitivity detection of biotinylated molecules. Scenario-driven insights guide biomedical researchers in protocol optimization, troubleshooting, and vendor selection, with evidence-backed recommendations for integrating this reagent into advanced workflows.
-
Phenytoin in Sodium Channel Modulation: Applied Protocols &
2026-06-05
Phenytoin (5,5-diphenylimidazolidine-2,4-dione) stands out as a high-purity, DMSO-soluble tool for sodium channel modulation research and enzyme inhibition assays. This guide bridges reference findings and advanced workflows, offering actionable troubleshooting advice for consistent, reproducible results in electrophysiology and neurological disease modeling.
-
Oscillatory mTORC1 Activity Regulates Cell Cycle and Autopha
2026-06-04
The referenced study demonstrates that mTORC1 activity is dynamically regulated throughout the cell cycle, with distinct peaks and troughs corresponding to specific phases. This phase-specific oscillation critically coordinates mitotic entry and modulates autophagy induction, revealing new mechanistic insights for cell cycle and metabolic research.
-
Tigecycline in Translational Research: From Mechanism to Imp
2026-06-04
Explore how Tigecycline—a first-in-class glycylcycline antibiotic—empowers translational researchers confronting multidrug-resistant pathogens. Blending mechanistic insight with strategic guidance, this article examines recent breakthroughs in resistance transmission, workflow optimization, and the clinical implications for complicated infections.
-
Deracoxib and Piroxicam Cytotoxicity in Canine Osteosarcoma
2026-06-03
This study systematically compares the cytotoxic effects of Deracoxib and piroxicam on canine osteosarcoma cell lines, revealing that Deracoxib acts as a more potent inhibitor at intermediate and high concentrations, with minimal effect on fibroblasts. The findings clarify the concentration-dependent nature of selective COX-2 inhibitor action in cancer cell viability assays and inform future in vitro experimental design.
-
Methylprednisolone: Precision Tools for Translational Inflam
2026-06-03
This thought-leadership feature explores the mechanistic depth and translational implications of methylprednisolone as a synthetic glucocorticoid receptor agonist. With a blend of biological insight, experimental rigor, and strategic guidance, it distinguishes itself from standard product pages by connecting current in vivo and in vitro evidence to the evolving clinical landscape, and by offering actionable recommendations for translational researchers.
-
Hoechst 33342/PI Double Staining Kit: Technical Workflow Gui
2026-06-02
The Hoechst 33342/PI Double Staining Kit addresses the need for rapid, reliable differentiation of apoptotic, necrotic, and viable cells in fluorescence-based assays. It is intended for basic research, not for diagnostic or clinical use, and is best applied where chromatin condensation and cell membrane integrity must be assessed in parallel.
-
Phosbind Biotin LC: Practical Guide for Phosphorylation Dete
2026-06-02
Phosbind Biotin LC enables sensitive, sequence-independent detection of phosphorylated proteins on PVDF membranes for Western Blot workflows. It addresses scenarios where phospho-specific antibodies are limiting or unavailable, but is not suitable for aqueous-only protocols or long-term storage of working solutions.
-
CUDC-907: Technical Guidance for Dual PI3K and HDAC Inhibiti
2026-06-01
CUDC-907 addresses the need for precise, simultaneous inhibition of PI3K/AKT and histone deacetylase pathways in controlled in vitro cancer research. Its dual-target activity supports cell-based assays focused on cell signaling, cycle, and apoptosis modulation. It is not validated for diagnostic or clinical use and should be applied strictly within research protocols.
-
Adefovir (GS-0393): Optimizing HBV Antiviral Workflows in Re
2026-06-01
Adefovir (GS-0393) stands out as a dual-purpose agent for hepatitis B virus research and transporter phenotyping, offering reproducibility, selectivity, and robust mechanistic clarity. This article delivers actionable protocol guidance, troubleshooting insights, and a translational bridge from reference evidence to bench workflows, making APExBIO's Adefovir a research essential.
-
Selective IRAP Inhibitors via α-Hydroxy-β-Amino Acid Bestati
2026-05-31
This study introduces a highly diastereo- and regio-selective synthetic route to α-hydroxy-β-amino acid derivatives of bestatin, yielding potent and selective nanomolar inhibitors for insulin-regulated aminopeptidase (IRAP). Structural and biochemical analyses reveal crucial determinants of potency and selectivity, offering new chemical tools for targeting M1 zinc aminopeptidases in immunology and drug discovery.